Fagron shareholders approve all voting items AGM

Group 1 - Fagron held its annual general shareholders meeting where all voting items were approved [1] - The meeting approved Fagron's annual financial statements and a dividend proposal of €0.35 per share for the fiscal year 2024 [2] - The remuneration policy and the appointment of the statutory auditor for the financial years 2025 to 2027 were also approved [2] Group 2 - Ann Desender BV was reappointed as independent non-executive director until the annual general meeting of 2029 [2] - All meeting documents are available on Fagron's website, including the minutes of the meetings [3] - Fagron operates in over 30 countries, focusing on personalized medicine for hospitals, pharmacies, clinics, and patients [4] Group 3 - Fagron NV is registered in Nazareth and listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [5] - The operational activities are managed by Fagron BV, headquartered in Rotterdam [5] Group 4 - The dividend calendar includes an ex-dividend date of 19 May 2025, record date of 20 May 2025, and payment date of 21 May 2025 [7]